People : Shea Foundation Recognizes Engvall For Developing Enzyme-linked Assays, Biopharmaceutics Researcher Receives Inaugural Award From FIP; Obituary

Shea Foundation Recognizes Engvall For Developing Enzyme-linked Assays Biopharmaceutics Researcher Receives Inaugural Award From FIP James B. Pollack, Obituary Date: July 25, 1994, pp.22 Eva Engvall, a senior staff scientist at the La Jolla Cancer Research Foundation in California, received an award for scientific achievement from the Edmund and Mary Shea Family Foundation of Walnut, Calif., on July 7 for her invention of the

Written byNeeraja Sankaran

| 3 min read

Save for Later

Listen with Speechify

0:00

3:00

Shea Foundation Recognizes Engvall For Developing Enzyme-linked Assays

Biopharmaceutics Researcher Receives Inaugural Award From FIP

James B. Pollack, Obituary

Date: July 25, 1994, pp.22

Eva Engvall, a senior staff scientist at the La Jolla Cancer Research Foundation in California, received an award for scientific achievement from the Edmund and Mary Shea Family Foundation of Walnut, Calif., on July 7 for her invention of the enzyme-linked immunosorbent assay (ELISA). The $25,000 prize was presented to her at a special ceremony chaired by George E. Palade, a 1974 Nobel laureate in physiology or medicine.

The Shea Foundation, run by Edmund Shea, executive vice president and director of the J.F. Shea Co. of Walnut--a civil construction company and venture capital firm in the area of medicine--is interested in innovations in the biomedical field.

"My major contribution was in making the technique accessible," says Engvall, who worked on developing the ELISA test as ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member?